About NEURONETICS, INC.
NeuroStar TMS is a non-invasive, FDA-cleared treatment for depression, including Major Depressive Disorder (MDD), OCD, and anxious depression, offering relief without the common side effects of medication. It is used in over 230,000 patients with reported effectiveness in 83% of cases.
Non-invasive treatment for Major Depressive Disorder (MDD)FDA-cleared for OCD and anxious depressionTreatment without sedation or anesthesiaNo recovery time required after sessionsEffective for treatment-resistant depressionAccepted by most major insurance providers including Medicare and Tricare
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| THERAPEUTIC MAGNETIC SYSTEM ANNUAL MAINT MODEL # 81-00315-000 | Department of Defense | $20K | |
| Federal contract award | Department of Defense | $16K | |
| Federal contract award | Department of Defense | $11K | |
| HIGHLY SPECIALIZED HOSPITAL EQUIPMENT SERVICE AGREEMENT. | Department of Veterans Affairs | $10K | |
| 644-NEURONETICS TRANSCRANIAL MAGNETIC STIMULATORS PREVENTATIVE MAINTENANCE | Department of Veterans Affairs | $44K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NEURONETICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.